Marshall Wace North America’s Viridian Therapeutics VRDN Stock Holding History

Marshall Wace North America’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.23M	Buy	+75,000	New	+$1.1M	0.01%	858
2018 Q2	–	Sell	-807	Closed	-$85K	–	1711
2018 Q1	$85K	Buy	+807	New	+$87.7K	﹤0.01%	1372

Other funds holding VRDN

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Ally Bridge Group New York $101M AUM 249.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return